LeBeau AM - Search Results

1

Imaging active urokinase plasminogen activator in prostate cancer.

LeBeau AM, Sevillano N, Markham K, Winter MB, Murphy ST, Hostetter DR, West J, Lowman H, Craik CS, VanBrocklin HF. LeBeau AM, et al. Cancer Res. 2015 Apr 1;75(7):1225-35. doi: 10.1158/0008-5472.CAN-14-2185. Epub 2015 Feb 11. Cancer Res. 2015. PMID: 25672980 Free PMC article.

2

Prostate-specific antigen: an overlooked candidate for the targeted treatment and selective imaging of prostate cancer.

LeBeau AM, Kostova M, Craik CS, Denmeade SR. LeBeau AM, et al. Biol Chem. 2010 Apr;391(4):333-43. doi: 10.1515/BC.2010.044. Biol Chem. 2010. PMID: 20180648 Free PMC article. Review.

3

Antagonistic anti-urokinase plasminogen activator receptor (uPAR) antibodies significantly inhibit uPAR-mediated cellular signaling and migration.

Duriseti S, Goetz DH, Hostetter DR, LeBeau AM, Wei Y, Craik CS. Duriseti S, et al. Among authors: lebeau am. J Biol Chem. 2010 Aug 27;285(35):26878-26888. doi: 10.1074/jbc.M109.077677. Epub 2010 May 25. J Biol Chem. 2010. PMID: 20501655 Free PMC article.

4

Imaging a functional tumorigenic biomarker in the transformed epithelium.

LeBeau AM, Lee M, Murphy ST, Hann BC, Warren RS, Delos Santos R, Kurhanewicz J, Hanash SM, VanBrocklin HF, Craik CS. LeBeau AM, et al. Proc Natl Acad Sci U S A. 2013 Jan 2;110(1):93-8. doi: 10.1073/pnas.1218694110. Epub 2012 Dec 17. Proc Natl Acad Sci U S A. 2013. PMID: 23248318 Free PMC article.

5

Targeting uPAR with antagonistic recombinant human antibodies in aggressive breast cancer.

LeBeau AM, Duriseti S, Murphy ST, Pepin F, Hann B, Gray JW, VanBrocklin HF, Craik CS. LeBeau AM, et al. Cancer Res. 2013 Apr 1;73(7):2070-81. doi: 10.1158/0008-5472.CAN-12-3526. Epub 2013 Feb 11. Cancer Res. 2013. PMID: 23400595 Free PMC article.

6

Imaging the urokinase plasminongen activator receptor in preclinical breast cancer models of acquired drug resistance.

LeBeau AM, Sevillano N, King ML, Duriseti S, Murphy ST, Craik CS, Murphy LL, VanBrocklin HF. LeBeau AM, et al. Theranostics. 2014 Jan 18;4(3):267-79. doi: 10.7150/thno.7323. eCollection 2014. Theranostics. 2014. PMID: 24505235 Free PMC article.

7

Protease-activated pore-forming peptides for the treatment and imaging of prostate cancer.

LeBeau AM, Denmeade SR. LeBeau AM, et al. Mol Cancer Ther. 2015 Mar;14(3):659-68. doi: 10.1158/1535-7163.MCT-14-0744. Epub 2014 Dec 23. Mol Cancer Ther. 2015. PMID: 25537662 Free PMC article.

8

Non-invasive imaging and cellular tracking of pulmonary emboli by near-infrared fluorescence and positron-emission tomography.

Page MJ, Lourenço AL, David T, LeBeau AM, Cattaruzza F, Castro HC, VanBrocklin HF, Coughlin SR, Craik CS. Page MJ, et al. Among authors: lebeau am. Nat Commun. 2015 Oct 1;6:8448. doi: 10.1038/ncomms9448. Nat Commun. 2015. PMID: 26423607 Free PMC article.

9

The Rational Design of Therapeutic Peptides for Aminopeptidase N using a Substrate-Based Approach.

Joshi S, Chen L, Winter MB, Lin YL, Yang Y, Shapovalova M, Smith PM, Liu C, Li F, LeBeau AM. Joshi S, et al. Among authors: lebeau am. Sci Rep. 2017 May 2;7(1):1424. doi: 10.1038/s41598-017-01542-5. Sci Rep. 2017. PMID: 28465619 Free PMC article.

10

PEG10 Promoter-Driven Expression of Reporter Genes Enables Molecular Imaging of Lethal Prostate Cancer.

Shapovalova M, Lee JK, Li Y, Vander Griend DJ, Coleman IM, Nelson PS, Dehm SM, LeBeau AM. Shapovalova M, et al. Among authors: lebeau am. Cancer Res. 2019 Nov 1;79(21):5668-5680. doi: 10.1158/0008-5472.CAN-19-2181. Epub 2019 Sep 17. Cancer Res. 2019. PMID: 31530569 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

33 results

Search Page